Cargando…
Significance of Competing Metabolic Pathways for 5F-APINACA Based on Quantitative Kinetics
In 2020, nearly one-third of new drugs on the global market were synthetic cannabinoids including the drug of abuse N-(1-adamantyl)-1-(5-pentyl)-1H-indazole-3-carboxamide (5F-APINACA, 5F-AKB48). Knowledge of 5F-APINACA metabolism provides a critical mechanistic basis to interpret and predict abuser...
Autores principales: | Pinson, Anna O., Pouncey, Dakota L., Schleiff, Mary A., Fantegrossi, William E., Prather, Paul L., Radominska-Pandya, Anna, Boysen, Gunnar, Miller, Grover P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587938/ https://www.ncbi.nlm.nih.gov/pubmed/33092129 http://dx.doi.org/10.3390/molecules25204820 |
Ejemplares similares
-
Similar 5F-APINACA Metabolism between CD-1 Mouse and Human Liver Microsomes Involves Different P450 Cytochromes
por: Crosby, Samantha V., et al.
Publicado: (2022) -
Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics
por: Schleiff, Mary Alexandra, et al.
Publicado: (2021) -
Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N‐(adamantan‐1‐yl)‐1‐(5‐fluoropentyl)‐1H‐indole‐3‐carboxamide (STS‐135)
por: Jones, Sabrina, et al.
Publicado: (2020) -
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development
por: Ford, Benjamin M., et al.
Publicado: (2016) -
In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters
por: Kim, Sunjoo, et al.
Publicado: (2019)